Literature DB >> 10776924

Herpesviruses and periodontopathic bacteria in Trisomy 21 periodontitis.

D Hanookai1, H Nowzari, A Contreras, J L Morrison, J Slots.   

Abstract

BACKGROUND: Little is known about the etiology and pathogenesis of periodontal disease in Trisomy 21 patients. This study determined the occurrence of herpesviruses and putative periodontopathic bacteria in Trisomy 21 periodontitis.
METHODS: Nineteen Trisomy 21 patients (17 to 37 years of age) contributed subgingival samples from molar and bicuspid teeth presenting interproximal periodontitis lesions (probing depths, 5 to 8 mm) and from shallow periodontal sites (probing depths, 1 to 3 mm). Samples were obtained at baseline, and at 1 and 4 weeks after subgingival debridement by means of hand instruments and ultrasonic scalers. Epstein-Barr virus type 1 and 2 (EBV-1 and EBV-2), human cytomegalovirus (HCMV), and herpes simplex virus (HSV) were identified by sensitive and specific nested polymerase chain reaction. Putative periodontopathic bacteria were identified by means of non-selective and selective culture.
RESULTS: Of 19 Trisomy 21 periodontitis lesions, 6 (32%) were positive for EBV-1, 5 (26%) were positive for HCMV, 3 (16%) were positive for HSV, and 2 (11%) showed viral co-infection. Of 19 shallow periodontal sites, only one revealed HCMV. Prevotella intermedia, Bacteroides forsythus, and Capnocytophaga species were detected in higher proportions in deep than in shallow periodontal pockets (P = 0.02). Subgingival debridement did not reduce genomic herpesvirus presence but caused a decrease in proportions of Porphyromonas gingivalis and Capnocytophaga species.
CONCLUSIONS: Periodontal herpesvirus-bacteria coinfections may play important roles in the pathogenesis of destructive periodontal disease in Trisomy 21 patients. Herpesviruses may reduce the periodontal defense and promote growth of subgingival bacteria capable of causing periodontal breakdown.

Entities:  

Mesh:

Year:  2000        PMID: 10776924     DOI: 10.1902/jop.2000.71.3.376

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  7 in total

1.  The effect of conventional mechanical periodontal treatment on red complex microorganisms and clinical parameters in Down syndrome periodontitis patients: a pilot study.

Authors:  M H Tanaka; T O Rodrigues; L S Finoti; S R L Teixeira; M P A Mayer; R M Scarel-Caminaga; E M A Giro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-04       Impact factor: 3.267

Review 2.  The oral microbiome diversity and its relation to human diseases.

Authors:  Jinzhi He; Yan Li; Yangpei Cao; Jin Xue; Xuedong Zhou
Journal:  Folia Microbiol (Praha)       Date:  2014-08-23       Impact factor: 2.099

3.  Association of Herpes Viruses with Mild, Moderate and Severe Chronic Periodontitis.

Authors:  Mohammad Mukhit Abdul Gaffar Kazi; Renu Bharadwaj; Kishore Bhat; Daisy Happy
Journal:  J Clin Diagn Res       Date:  2015-07-01

4.  Subgingival microbiota in adult Down syndrome periodontitis.

Authors:  A Khocht; T Yaskell; M Janal; B F Turner; T E Rams; A D Haffajee; S S Socransky
Journal:  J Periodontal Res       Date:  2012-01-03       Impact factor: 4.419

Review 5.  Prevention and Periodontal Treatment in Down Syndrome Patients: A Systematic Review.

Authors:  Rafael Ferreira; Raphaella Coelho Michel; Sebastião Luiz Aguiar Greghi; Maria Lúcia Rubo de Resende; Adriana Campos Passanezi Sant'Ana; Carla Andreotti Damante; Mariana Schutzer Ragghianti Zangrando
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

6.  Relationship between herpesviruses and periodontal disease progression.

Authors:  Pinar Emecen-Huja; Robert J Danaher; Dolphus R Dawson; Chunmei Wang; Richard J Kryscio; Jeffrey L Ebersole; Craig S Miller
Journal:  J Clin Periodontol       Date:  2020-02-03       Impact factor: 7.478

7.  Association between Herpesviruses and Chronic Periodontitis: A Meta-Analysis Based on Case-Control Studies.

Authors:  Ce Zhu; Fei Li; May Chun Mei Wong; Xi-Ping Feng; Hai-Xia Lu; Wei Xu
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.